Zühlke vs Jabil Healthcare: full comparison for 2026
Quick verdict
Zühlke (4.4/5) edges ahead of Jabil Healthcare (3.8/5) overall. Zühlke is the better choice for european medtech firms modernizing device software. Jabil Healthcare is the stronger option for global production capacity for cleared devices. The right choice depends on your project size, budget, and required tech stack.
Zühlke vs Jabil Healthcare: head-to-head summary
| Criterion | Zühlke | Jabil Healthcare |
|---|---|---|
| Founded | 1968 | 1966 |
| HQ | Schlieren, Switzerland | St. Petersburg, FL, USA |
| Team size | 1,500–2,000 | ~20,000 (healthcare) |
| Rating | 4.4 / 5 | 3.8 / 5 |
| Primary differentiator | A device engineering practice and a large digital practice under one owner, useful when a device program is really a platform program | Global scale, supply chain and FDA-registered production for established medical device brands |
| Pricing model | Time and materials, fixed project | Manufacturing supply agreement, NPI contract |
| Min. engagement | Not disclosed | Not disclosed |
| Primary tech stack | Embedded C/C++, Embedded Linux, Cloud (AWS/Azure) | Injection molding, Automated assembly, PCB assembly |
| Industries served | Digital health, Diagnostics & lab devices, Surgical & therapeutic devices, Financial services | Surgical & robotics, Drug delivery, Wearables & remote monitoring, Consumer health |
Zühlke vs Jabil Healthcare: overview
Zühlke
Partner-owned since its 1968 founding in Switzerland, Zühlke is headquartered in Schlieren near Zurich, with teams in Germany, Austria, the UK, Serbia and Asia. Its headcount is somewhere between 1,500 and 2,000 depending on the source. In healthcare it covers regulated device and systems engineering, connected-device software and the cloud and analytics platforms around devices, and it states more than 50 years of medtech experience (per company website; independently unverifiable).
Jabil Healthcare
Jabil Healthcare was formed in 2020 when Jabil combined its Nypro business with its orthopedics, spine and trauma units. At launch it had nearly 20,000 employees and more than 35 sites, and its factories producing finished medical devices are FDA registered. It covers minimally invasive devices, surgical robotics, complex catheters, diabetes care and consumer health, and the acquisition of CDMO Pii extended it into drug development and aseptic fill-finish. Jabil reported $8.3 billion in company-wide revenue for its second fiscal quarter of 2026.
Services and capabilities: Zühlke vs Jabil Healthcare
| Capability | Zühlke | Jabil Healthcare |
|---|---|---|
| Electronics & PCB design | ✓ | ✓ |
| Firmware & embedded software | ✓ | ✗ |
| SaMD & companion apps | ✓ | ✗ |
| Connected devices & IoT | ✓ | ✗ |
| Industrial design & human factors | ✗ | ✗ |
| Mechanical engineering | ✗ | ✓ |
| Device cybersecurity | ✗ | ✗ |
| Regulatory & QMS support | ✓ | ✓ |
| Manufacturing & scale-up | ✗ | ✓ |
Tech stack comparison: Zühlke vs Jabil Healthcare
| Framework / platform | Zühlke | Jabil Healthcare |
|---|---|---|
| Embedded C/C++ | ✓ | N/A |
| Embedded Linux | ✓ | N/A |
| RTOS | N/A | N/A |
| BLE | N/A | N/A |
| Cloud (AWS/Azure) | ✓ | N/A |
| IEC 62304 | ✓ | N/A |
| ISO 14971 | N/A | N/A |
| ISO 13485 QMS | N/A | ✓ |
| Qt | ✓ | N/A |
Pricing comparison: Zühlke vs Jabil Healthcare
| Criterion | Zühlke | Jabil Healthcare |
|---|---|---|
| Minimum engagement | Not disclosed | Not disclosed |
| Engagement models | Consulting, Dedicated team, Fixed project, Time & materials | Manufacturing contract |
| Rate transparency | Not public | Not public |
| Price tier | Mid-market | Mid-market |
Target audience comparison: Zühlke vs Jabil Healthcare
| Dimension | Zühlke | Jabil Healthcare |
|---|---|---|
| Best company size | Startup to mid-market | Startup to mid-market |
| Best industries | Digital health, Diagnostics & lab devices, Surgical & therapeutic devices | Surgical & robotics, Drug delivery, Wearables & remote monitoring |
| Best use cases | Rebuilding the embedded and cloud software of an established diagnostics platform, EU MDR remediation of legacy device software | Scaling production of a cleared diabetes device, Global manufacturing of a surgical robotics subsystem |
| Typical project type | Consulting | Manufacturing contract |
Zühlke vs Jabil Healthcare: pros and cons
| Zühlke | |
|---|---|
| + | Partner ownership keeps the firm independent of a large holding group |
| + | Large enough to staff hardware, embedded, cloud and data roles at the same time |
| + | Delivery centres in Serbia and Asia give some cost flexibility compared with all-Swiss teams |
| + | Experience with EU MDR environments in German-speaking markets |
| - | Much of the firm works outside healthcare, so check that the proposed team is from the medtech practice |
| - | Swiss and German rates are high for the onshore part of a team |
| - | Industrial design and manufacturing are not core offerings |
| Jabil Healthcare | |
|---|---|
| + | One of the largest healthcare manufacturing networks in the world |
| + | FDA-registered sites for finished devices |
| + | Strong supply chain management during component shortages |
| + | Covers drug delivery through the Pii acquisition |
| - | Built for production volume; early design and invention are outside its main business |
| - | Small companies may struggle to get attention |
| - | Engineering support is tied to manufacturing programs |
Who should choose Zühlke?
A typical fit: rebuilding the embedded and cloud software of an established diagnostics platform.
A device engineering practice and a large digital practice under one owner, useful when a device program is really a platform program. Minimum engagement is not publicly disclosed. Works best with clients in Digital health, Diagnostics & lab devices, Surgical & therapeutic devices, Financial services.
Who should choose Jabil Healthcare?
A typical fit: scaling production of a cleared diabetes device.
Global scale, supply chain and FDA-registered production for established medical device brands. Minimum engagement is not publicly disclosed. Works best with clients in Surgical & robotics, Drug delivery, Wearables & remote monitoring, Consumer health.
Decision matrix: Zühlke vs Jabil Healthcare
| Your situation | Recommended choice |
|---|---|
| You need full-ownership delivery on a defined project scope | Zühlke |
| You need a large dedicated team for an ongoing programme | Zühlke |
| Your budget is at the lower end | Compare: Zühlke (Not disclosed) vs Jabil Healthcare (Not disclosed) |
| You need specialist depth in a specific vertical | Zühlke |
| You need staff augmentation or team extension | Neither; consider alternatives that offer staff aug |
| You need consulting before committing to a build | Both may offer discovery engagements |
Use case fit: Zühlke vs Jabil Healthcare
| Use case | Zühlke fit | Jabil Healthcare fit | Winner |
|---|---|---|---|
| Rebuilding the embedded and cloud software of an established diagnostics platform | Strong | Limited | Zühlke |
| EU MDR remediation of legacy device software | Strong | Limited | Zühlke |
| Scaling production of a cleared diabetes device | Limited | Strong | Jabil Healthcare |
| Global manufacturing of a surgical robotics subsystem | Limited | Strong | Jabil Healthcare |
Verdict: Zühlke vs Jabil Healthcare
Zühlke (4.4/5) is the stronger overall choice for most Medical Device Development projects. A device engineering practice and a large digital practice under one owner, useful when a device program is really a platform program.
Jabil Healthcare (3.8/5) is worth a look if you need global manufacturing of a surgical robotics subsystem. If your situation matches that, Jabil Healthcare is a competitive option.
Related comparisons
Zühlke vs Jabil Healthcare FAQ
Is Zühlke better than Jabil Healthcare?
Zühlke (4.4/5) scores higher overall, but "better" depends on your use case. Zühlke's strongest advantage: partner ownership keeps the firm independent of a large holding group. Jabil Healthcare's strongest advantage: one of the largest healthcare manufacturing networks in the world.
How do Zühlke and Jabil Healthcare differ in pricing?
Zühlke uses time and materials, fixed project pricing. Jabil Healthcare uses manufacturing supply agreement, npi contract pricing. Neither firm publishes a full rate card; a discovery call is required for project-specific quotes.
Which is better for enterprise: Zühlke or Jabil Healthcare?
Zühlke is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each company before shortlisting.
What are the main differences between Zühlke and Jabil Healthcare?
Zühlke's primary differentiator is: a device engineering practice and a large digital practice under one owner, useful when a device program is really a platform program. Jabil Healthcare's primary differentiator is: global scale, supply chain and FDA-registered production for established medical device brands. They also differ in team size (1,500–2,000 vs ~20,000 (healthcare)), minimum engagement (Not disclosed vs Not disclosed), and primary industries served (Digital health, Diagnostics & lab devices vs Surgical & robotics, Drug delivery).
Verify all details directly with each company before making a decision.